How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

    The content on this page is not current guidance and is only for the purposes of the consultation process.

    Bioresorbable stent implantation to treat coronary artery disease

    Closed for comments This consultation ended on at   Request commenting lead permission

    1 Draft recommendations

    1.1 Evidence on the efficacy of bioresorbable stent implantation to treat coronary artery disease is inadequate. Evidence on its safety has shown an increased risk of serious complications in the longer term. This includes an increased risk of myocardial infarction and death with some types of bioresorbable stents. Therefore, this procedure should only be used in the context of research. Find out what only in research means on the NICE interventional procedures guidance page.

    1.2 Clinicians should enter details about everyone having bioresorbable stent implantation to treat coronary artery disease into the National Institute for Cardiovascular Outcomes Research's National Audit of Percutaneous Coronary Interventions. Contact bartshealth.nicor-generalenquiries@nhs.net for details.

    1.3 Further research should include randomised controlled trials reporting details of patient selection and choice of bioresorbable stent. It should also include long-term outcomes.